Compounds > methotrexate
Page last updated: 2024-08-25

methotrexate and Coronary Restenosis

methotrexate has been researched along with Coronary Restenosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, YG; Kwon, OC; Oh, JS1
Gunn, J; Morton, AC1

Other Studies

2 other study(ies) available for methotrexate and Coronary Restenosis

ArticleYear
In-stent Restenosis after Drug-eluting Stent Implantation in Rheumatoid Arthritis: Possible Protective Effect of Methotrexate.
    The Journal of rheumatology, 2018, Volume: 45, Issue:9

    Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cardiovascular Diseases; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Methotrexate; Middle Aged; Percutaneous Coronary Intervention; Treatment Outcome

2018
Methotrexate eluting stents: to modify or cure?
    Heart (British Cardiac Society), 2004, Volume: 90, Issue:2

    Topics: Animals; Coronary Restenosis; Equipment Failure; Folic Acid Antagonists; Humans; Methotrexate; Models, Animal; Models, Biological; Stents

2004